11.30

2.08% 0.23

Pre-market: 11.23 -0.07 -0.62%

Sionna Therapeutics Inc (SION)

Overview News Price History Discussions Forecast

Sionna Therapeutics Inc stock is traded at $11.30, with a volume of 97,910. It is up +2.08% in the last 24 hours and down -17.46% over the past month. Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

Previous Close:

$11.07

Open:

$10.57

24h Volume:

97,910

Relative Volume:

0.62

Market Cap:

$393.15M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+26.82%

1M Performance:

-17.46%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$10.07

$11.98

1-Week Range:

$8.60

$11.98

52-Week Range:

$7.255

$24.90

Sionna Therapeutics Inc Stock (SION) Company Profile

Name

Sionna Therapeutics Inc

Sector

Healthcare (1155)

Industry

Biotechnology (677)

Phone

617-819-2020

Address

21 HICKORY DRIVE, SUITE 500, WALTHAM

Employee

Twitter

Next Earnings Date

Latest SEC Filings

SION's Discussions on Twitter

Compare SION with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SION Sionna Therapeutics Inc	11.30	393.15M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	477.52	127.47B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	561.49	62.43B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	595.70	37.03B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	232.75	31.06B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	229.22	26.16B	3.81B	-644.79M	-669.77M	-6.24

Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-04-25	Initiated	Guggenheim	Buy
Mar-04-25	Initiated	Stifel	Buy
Mar-04-25	Initiated	TD Cowen	Buy

Sionna Therapeutics Inc Stock (SION) Latest News

Apr 07, 2025

Q1 IPOs Rise From Q4, But Unstable Markets Could Slow New Offerings - insights.citeline.com

Apr 07, 2025

Mar 31, 2025

In 2025, biotech IPOs were supposed to bounce back. It hasn't happened yet. - The Business Journals

Mar 31, 2025

Mar 28, 2025

Sionna Therapeutics (NASDAQ:SION) Trading Down 4.2%What's Next? - MarketBeat

Mar 28, 2025

Mar 22, 2025

Sionna Therapeutics (NASDAQ:SION) Reaches New 1-Year Low on Disappointing Earnings - Defense World

Mar 22, 2025

Mar 20, 2025

Stifel maintains Buy rating on Sionna Therapeutics stock at $32 target - Investing.com Australia

Mar 20, 2025

SEC Form 10-K filed by Sionna Therapeutics Inc. - Quantisnow

Mar 20, 2025

Form 10-K Sionna Therapeutics, For: Dec 31 - StreetInsider

Mar 20, 2025

Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Mar 20, 2025

SIONSionna Therapeutics Latest Stock News & Market Updates - StockTitan

Mar 20, 2025

Mar 17, 2025

Pre-market Movers: REVB, QSI, EYEN, NAOV ... - RTTNews

Mar 17, 2025

Mar 15, 2025